Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles + mumps + rubella vaccine + yellow fever vaccine
- Development stage
- Unknown
- Lead developer
- Sanofi Pasteur
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intramuscular
01
Overview
This drug entry refers to a co-administration regimen involving a live-attenuated measles, mumps, and rubella (MMR) vaccine and a live-attenuated yellow fever vaccine. Developed and evaluated by Sanofi, the regimen specifically focuses on the investigational Vero-cell derived yellow fever vaccine (vYF) compared to licensed egg-derived counterparts like Stamaril and YF-VAX. The combination is intended for pediatric populations, particularly infants and children aged 9 months to 5 years, to provide synchronized protection against measles, mumps, rubella, and yellow fever. Clinical evaluation in Phase III trials (such as VYF04) aims to demonstrate that simultaneous administration maintains the safety and immunogenicity of each individual component without interference.
- Brand names
- StamarilYF-VAX
- Other names
- measles + mumps + rubella (live attenuated)-Sanofi-yellow feverMMR + YFvYF + MMRMMR vaccine + yellow fever vaccine
Beyond the preview
Go deeper on measles + mumps + rubella vaccine + yellow fever vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles + mumps + rubella vaccine + yellow fever vaccine.